Taking the medication mavacamten for HCM can reduce obstruction in your heart. Learn about its benefits, risks, and side ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMSOUTH SAN FRANCISCO, Calif., ...

Learn about sudden cardiac death risk in people with hypertrophic cardiomyopathy, including risk factors, prevention methods, ...

As if it were yesterday, I recall the death of 18-year-old Ben Breedlove, who suffered from hypertrophic cardiomyopathy (HCM), an ailment in which I specialize as a pediatric cardiologist. I have seen ...

On Track with HCM” Features Practical Insights for Managing Everyday Life with the Disease, Inspired by the Experience with ...

The number of patients diagnosed with cardiomyopathy has increased substantially over the past two decades. This is the ...

A multicentre study shows AI-enabled ECG screening can be integrated into clinical workflows to detect previously undiagnosed hypertrophic cardiomyopathy and accelerate follow-up.

For Derek Johnson of Lethbridge, Alta., the signs of a heart problem piled up slowly. At first, too slowly to alarm him. Derek became winded mowing the lawn. He had trouble concentrating at work. But ...

What is Hypertrophic Cardiomyopathy (HCM)? Hypertrophic cardiomyopathy (HCM) is a condition that affects the muscle layer of the heart in patients without any underlying heart problems or systemic ...

Hypertrophic cardiomyopathy is an underdiagnosed genetic disorder, resulting from mutations in sarcomeric proteins. It has a highly variable clinical presentation, with some individuals remaining ...